USPTO serial 97727259
ARGENX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 3, 2024
- Examiner
- KNIGHT, TROY FRANK
- Law office
- PETITIONS OFFICE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ARGENX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zwijnaarde, BE
Zwijnaarde, BE
Zwijnaarde, BE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Edward T. White
Edward T. White Williams Mullen200 South 10th Street, Suite 1600c/o IP DocketingRichmond, VA 23219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system | ACTIVE | — |
| 035 | Wholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namely, providing consumer product information in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information, namely, providing consumer product information relating to pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs | ACTIVE | — |
| 042 | Research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research, design, analysis, and testing in the field of immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development | ACTIVE | — |
| 044 | Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by argenx B.V.
- Other trademarks owned by argenx B.V.
- Other trademarks owned by argenx B.V.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ARGENX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 3, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 3, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Sep 3, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 12, 2024 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jul 10, 2024 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 18, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2024 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| May 29, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 15, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 15, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 24, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 22, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 19, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 19, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 19, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 19, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 14, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 4, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 19, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2022 | NWAP | NEW APPLICATION ENTERED | — |